Dudediligence.

Medline Inc

MDLNNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$3,650,000

1 notice · 100,000 sh

Oct 2025 to Oct 2026

Reported ·

$13.71B

38 sales · 5 buys · $515.0M bought

Oct 2025 to Jun 2026

The two figures cover different periods.

2 of 38 reported sales carry the 10b5-1 box.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-06-16: Douglas Golwas, Form 1442025-12-18: Mills Charles N., bought2025-12-18: Mills Andrew J., bought2025-12-18: SCHWARZMAN STEPHEN A, sold2025-12-18: GIC Private Ltd, sold2025-12-18: GIC Private Ltd, bought2025-12-18: HFCP X (Parallel-A), L.P., sold2025-12-18: TC Group, LLC, sold2025-12-18: Carlyle Mozart Coinvestment Holdings, L.P., sold2025-12-18: TC Group VII S1, L.P., sold2026-03-10: Blackstone Management Associates VIII L.P., sold2026-03-10: SCHWARZMAN STEPHEN A, sold2026-03-10: HFCP X (Parallel-A), L.P., sold2026-03-10: TC Group Cayman Investment Holdings, L.P., sold2026-03-10: CP Circle ML-1 Holdco GP, LLC, sold2026-03-10: Carlyle Mozart Coinvestment Holdings, L.P., sold2026-03-10: TC Group, LLC, sold2026-05-28: Blackstone Management Associates VIII L.P., sold2026-05-28: SCHWARZMAN STEPHEN A, sold2026-05-28: HFCP X (Parallel-A), L.P., sold2026-06-05: CORCORAN JESSI L, bought2026-06-16: Golwas Douglas P, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-06-16Douglas Golwas, Chief Commercial Officer$3,650,000
100,000 shplan 2026-03-11144 ↗
Form 4, 2026-06-17: sold 100,000 at $36.77Reflects sales effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026. Form 4 ↗